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Abstract 
The last decade has included unprecedented economic, scientific, technological, and 
social changes that have made it necessary to reevaluate the type of career tracks 
available to trainees and early career professionals in nicotine and tobacco science.  
The goal of the present commentary is to reflect on our collective experiences as early 
career nicotine and tobacco scientists working in the United States, the United 
Kingdom, and the Netherlands in an effort to provide perspective on what we see as 
four key factors have been most influential with regards to science-related career 
planning in recent years: 1) employment opportunities (e.g., increasing number of 
graduate degrees and limited growth among traditional academic positions), 2) 
economic and financial considerations (e.g., shifts in research funding), 3) scientific and 
regulatory environments (e.g., changing regulation of tobacco products), and 4) clinical 
and social environments.  Our commentary reviews the unique career opportunities that 
these factors have created for trainees and early career professionals including 
collaborative work across different research areas or science sectors (e.g., academia, 
government, and private sectors).  In addition, career-related resources of value to early 
career scientists, as well as academic institutions, mentors, and professional 
organizations are provided.  We are hopeful that increased discussion around the 
changes impacting nicotine and tobacco science in the 21st century can invigorate 
efforts to train scientists, promote diversity of thought, and facilitate the conduct and 
sharing of high quality nicotine and tobacco science inside and outside of the laboratory. 
Implications 
Unprecedented economic, scientific, technological, and social changes have made it 
necessary to reevaluate the type of career tracks available to trainees and early career 
professionals in nicotine and tobacco science.  The acknowledgement that science 
career trajectories are evolving as we move into the 21st century can invigorate efforts to 
train scientists, promote diversity of thought, and facilitate the conduct and sharing of 
high quality nicotine and tobacco science inside and outside of the laboratory.
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Introduction 
Unprecedented economic, scientific, technological, and social changes have made it 
necessary to reevaluate the type of career tracks available to trainees and early career 
scientists and clinicians.  The impact of these changes on science-related career tracks 
has been discussed more generally in recent years1,2, but less so with respect to 
nicotine and tobacco science. The goal of the present commentary is to reflect on our 
collective experiences as early career nicotine and tobacco scientists working in the 
United States, the United Kingdom, and the Netherlands in order to provide information, 
resources, and additional considerations for trainees and early career scientists 
navigating careers in nicotine and tobacco science.  We have identified four key 
developments that have impacted career planning in nicotine/tobacco science and each 
are discussed in greater detail below: 1) employment opportunities, 2) economic and 
financial challenges, 3) scientific and regulatory environments, and 4) clinical and social 
environments.  
Key Developments in the Field of Nicotine and Tobacco Science 
Education and Employment Opportunities 
A 2012 survey of 130 members of SRNT found that the majority of trainees (85%) 
hoped to work in an academic setting.3 Similarly, 78% of respondents to a 2015 survey 
of trainees in Europe, Asia, and North America reported that they intended to pursue a 
research career in academia.4  Unfortunately, statistics suggest that there is a shortage 
of academic positions worldwide with graduate degrees being awarded at a far greater 
rate than the number of career opportunities in academia.2,5  The degree to which these 
shifts in training and traditional academic employment opportunities have impacted the 
field of nicotine and tobacco science is not clear at this time.  However, our collective 
experience supports the idea that there has been growth in non-traditional career tracks 
outside of academia in nicotine and tobacco science due to changes in economic and 
regulatory environments, as noted below.  
Economic and Financial Considerations 
Despite large investments in science from many private and public organizations over 
the past century,6,7 the economic downturn in the early 2000s and other factors have 
had a considerable impact on research funding.  For example, the leading public funder 
of biomedical research in the world, the US National Institutes of Health7 (NIH), has 
seen a 13.4% reduction in budget (adjusted for inflation) across the last ten years 
according to estimates from the American Association for the Advancement of Science.8 
However, in the US during the same period of time a new source of funding for nicotine 
and tobacco research was established by the passing of the 2009 Tobacco Control Act 
(TCA).  The TCA established the Center for Tobacco Products (CTPs) and called for 
funding of CTP-related activities including the Tobacco Centers of Regulatory Science 
(TCORS) via tobacco company user fees rather than through discretionary spending of 
which supports NIH-related funding.  Due to this unique arrangement the CTP and 
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related Tobacco Regulatory Science (TRS) research is funded for the foreseeable 
future unless there is an act of Congress that would change the TCA.  Coinciding with 
shifts in funding is the reality of rising higher education costs and student loan burden 
faced by many trainees.9  These economic and financial changes have the potential to 
influence not only the funding environment of nicotine and tobacco scientists, but also 
the work environment given that restricted funding or student loan burden combined 
with institutional requirements can create an increasingly stressful and hypercompetitive 
work environment for scientists.10 We were unable to find any published literature 
addressing the impact of the above economic factors on nicotine and tobacco research, 
but our personal experience confirms that such factors play an important role in the 
career planning of trainees and early career professionals.  
Scientific and Regulatory Environment 
Collaborative and Global Research Efforts.  There has been a push for 
biomedical research to become more collaborative in recent years with a shift away 
from smaller research groups to larger scale projects involving global research teams 
across a variety of academic, government, and private sector stakeholders.1,6 Such 
collaborations are reflected by the recent announcement of a state-of-the-art, industrial-
scale brain imaging hub in China which will permit scientists across the world to 
collaboratively map neural connectivity in mice and humans.11 Similarly, with respect to 
nicotine and tobacco research, collaborative efforts to improve tobacco control efforts 
on a global level have been emphasized, especially in regions such as low- and middle-
income countries .12 Impactful collaborative efforts are also represented by The 
International Tobacco Control Policy Evaluation Project (http://www.itcproject.org) which 
was initiated in the early 2000s as the first-ever international cohort study of tobacco 
use. 
Research Ethics and Scientific Integrity.  Regulatory requirements for research 
ethics protection in the form of Institutional Review Boards (IRBs) or Ethics Review 
Boards have been increasing in the last two decades in some parts of the world.13 
These requirements, while necessary and important, have contributed to unique 
challenges faced by researchers and IRBs including demands on time and resources in 
order to review applications and meet requirements.  Relatedly, unique challenges to 
scientific integrity have evolved over the last decade.  Some scientists have suggested 
that the publish or perish mentality of science, combined with intense competition for 
research funding has created a “perverse incentive system” that contributes to unethical 
research practices.10  With respect to the nicotine and tobacco field, there are evolving 
non-financial and financial conflicts of interest with the potential to influence science due 
to changes in tobacco products and regulation.  Such changes necessitate an emphasis 
on training in scientific integrity, as noted in a recent paper on mentorship in tobacco 
regulatory science.14 The result of these and other demands on scientists can contribute 
to issues such as data falsification, ‘p-hacking’ or ‘spinning’ of research findings, faked 
peer review, predatory publishers, and more broadly a ‘reproducibility crisis’ for 
research findings.15  One approach for addressing these challenges has included the 
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creation of on-line resources for tracking unethical publishing behavior. (e.g., the official 
US channel of the Office of Research Integrity, www.ori.hhs.gov, as well as unofficial 
channels:www.retractionwatch.com and http://beallslist.weebly.com/).  Other initiatives 
include a move to open science practices which emphasize transparency and 
reproducibility of scholarly research, as well reforming the peer-review process with 
efforts such as pre- and/or post- publication review of manuscripts (e.g., PubMed 
Commons) .15 
Technological Innovation. Although rates of smoking have declined in some 
countries, they remain high in many developing countries and for some populations 
making the need for innovative research to reduce smoking rates an urgent public 
health priority.16 The development of new, approved medications for the treatment of 
tobacco dependence has lagged since the advent of varenicline as a prescribed 
treatment in the early 2000s.  In contrast, the availability of novel tobacco-related 
products such as electronic cigarettes has increased in recent years and the role that 
these devices will play in tobacco dependence has been debated.17  Innovative 
research methods have also evolved over the last decade to include web- and cloud-
based access to data sources such as electronic medical records (EMR) and “smart” 
devices, as well as crowdsourcing for data collection and research funding (e.g., 
Mechanical Turk, https://www.mturk.com/mturk/welcome).  These new products and 
research strategies offer exciting opportunities for early career scientists hoping to find a 
niche in the field of nicotine and tobacco science inside or outside the laboratory, 
including those that are interested in regulatory science.14,18   
Clinical and Social Environment 
Major changes within the field of nicotine and tobacco science have also occurred within 
the clinical/healthcare environment. Reimbursement rates have not kept pace with 
inflation and time demands for non-billable activities (e.g. documentation) have 
continued to increase. Concurrently, the increased integration of behavioral health into 
primary care settings is a promising avenue for achieving better access to smoking 
cessation services and other preventative care for tobacco use, though one that comes 
with many challenges.19   Additionally, the last two decades have also seen an increase 
in awareness of social issues impacting scientific and clinical environments such as 
issues related to diversity, social justice, and equity in the careers and research 
activities of scientists and clinicians.20,21,22  For example, a recent analysis of NIH R01 
funding noted that fewer awards were received or applied for by women of color as 
compared to white men and women indicative of NIH funding gaps related to gender 
and race/ethnicity.22 Such concerns build on growing concerns related to the “leaky 
pipeline” concept that is characterized by women in science, technology, engineering, 
and mathematics (STEM)-related occupations being more likely to leave their field 
compared to other professional fields of study. Psychology-related fields such as 
nicotine and tobacco science might be particularly impacted by such issues given the 
high numbers of women earning doctorate degrees relative to men in recent years.   
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Career Planning for Trainees and Early Career Professionals 
As depicted in Figure 1, there are a variety of career trajectories available to trainees 
and early career professionals across the varying stakeholders that influence and drive 
nicotine and tobacco and tobacco science (e.g., Academia, Government, Private).  
There is substantial overlap among many of these trajectories and they do not 
necessarily represent discrete paths.  For example, clinicians can concurrently conduct 
clinical hours as well as university-level research, while individuals in the private sector 
may hold adjunct teaching positions at academic institutions. As noted previously, 
collaborative work in science is becoming increasingly important and unique 
approaches to working collaboratively highlight the exciting opportunities available to 
early career scientists and clinicians as they move forward in their careers. As noted in 
a recent publication addressing neuroscience training in the 21st century, “Training in 
teams that include biotechnology or industry partners, clinicians, patient advocates, 
experts in regulatory affairs, and bioethicists, among others, would foster more 
successful translation from the bench than in the past.”1 Such findings correspond to 
results from a qualitative analysis of mentoring in the field of TRS in which early career 
TRS professionals emphasized their need to “develop and nurture a broad professional 
network across scientific fields and disciplines.” 14p.7  Along these lines, trainees and 
early career professionals looking to diversify their training on their own initiative might 
find the additional resources listed in Table 1 helpful.  Table 1 includes hyperlinks 
associated with a range of topics including careers inside and outside of academia, 
career planning, funding, fellowships, law/regulation/policy, and medical writing. While 
Table 1 does not include an exhaustive list of available resources, it does give an 
overview of the varied and unique opportunities that are available to the highly trained 
professionals such as those in the field of nicotine and tobacco science. Ideally, the 
content in Figure 1 and Table 1 can prompt mentors, professional organizations, and 
other influential decision makers to incorporate these varied opportunities into training 
and career-related guidance.   
Future Directions and Recommendations 
As summarized in this commentary, the evolving career landscape of scientists in 
general, as well as nicotine/tobacco scientists and clinicians, has created unique 
opportunities for trainees and early career professionals in nicotine/tobacco science.  
We consider our commentary a call to action for those involved in the field of nicotine 
and tobacco science to consider the impact that these factors described in our 
commentary will have on nicotine/tobacco science in the 21st century.  For trainees and 
early career professionals we recommend the following: 1) Understand and monitor the 
various factors impacting nicotine/tobacco science in the 21st century (e.g., trends in 
employment or funding), 2) Seek out opportunities to interact/work with individuals from 
various distinct career paths, including those outside traditional settings (e.g. 
academia), 3) Critically evaluate your unique skillsets to determine those that set you 
apart from others in the field and seek out supplemental training accordingly (e.g., 
advanced training in particular statistical methods), 4) Determine what aspects of your 
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work as a researcher and/or clinician that have been most rewarding and engaging, and 
look for careers that best align with those interests and values.   
In addition, those involved in the training of our next generation of nicotine and tobacco 
scientists, such as mentors, institutions, and professional organizations, should consider 
the possibility that some trainees will opt-out of the “traditional” academic career track. 
Such a choice might be due to a variety of reasons including unique skillsets that are 
better served in non-academic positions, economic constraints including funding cuts, 
as well as the evolving nature of the job market including new career opportunities in 
nicotine/tobacco science (e.g. government positions in regulatory science, tech-sector 
jobs). Efforts to offer career support that take into account these changes include 
connecting trainees with early career professionals, as exemplified in recent years by 
the Trainee Network Advisory Board of SRNT3,23, organizing career panels that 
represent diverse career options, and providing interdisciplinary training inside and 
outside of academia, as suggested by a recent National Institutes of Health Biomedical 
Research Workforce Working Group Report.24     
Our review of the literature also highlighted important topics that have yet to be explored 
within the field of nicotine and tobacco science as they pertain to training and career 
planning.  For example, it is unclear if the observed reductions in research funding seen 
more generally for science are also being observed by early career nicotine and 
tobacco scientists/clinicians.  As noted, it could be the case in the US that NIH funding 
cuts have been offset by increased funding from FDA/CTP. While this added source of 
funding is no doubt a net positive for junior investigators seeking support for their 
research, it does constrain research to that related to TRS and thus could alter the 
research landscape generated by our next cohort of nicotine/tobacco researchers.  
Similarly, concerns related to research ethics that have been discussed more broadly 
for science including the lack of reproducibility of many research findings14 have not 
been fully explored in the published literature on nicotine and tobacco.  More attention 
to these and other factors impacting the future of nicotine and tobacco science will be 
invaluable for informing trainees and early career professionals in the field.   
A last point to emphasize is generalizability of our commentary suggestions.  While our 
training and career experiences in the US and EU are representative of the majority of 
members in the Society for Research on Nicotine and Tobacco (SRNT; approximately 
81% of SRNT members are employed in these regions according to M. Johnson 
personal communication, August 4, 2017), we are sensitive to the fact that there are 
unique and varying challenges faced by early career scientists throughout the world.  
Trainees’ and early career professionals’ goals and needs will likely vary geographically 
and culturally, and career advice should respect these differences.4 For example, 
expectations of PhD students might vary by geographic region as demonstrated by PhD 
graduate training lasting longer on average in the US compared to the UK (e.g., 5-6 
years compared to 3-4 years).  In addition, nicotine/tobacco policy varies considerably 
depending on geography and such variation can impact training and employment 
opportunities.  However, despite such variation in training, we are hopeful that our 
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perspectives will provide a starting point for further discussion on careers in nicotine and 
tobacco science on a global level.  Overall, the acknowledgement that science career 
trajectories are evolving as we move into the 21st century can invigorate efforts to train 
scientists, promote diversity of thought, and facilitate the conduct and sharing of high 
quality nicotine and tobacco science inside and outside of the laboratory. 
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Table 1. Overview of Career-Related Resources in the Field of Nicotine/Tobacco Science 
Topic Area Weblink/URL  
  
Careers in Academia  
 
http://www.apa.org/monitor/2017/10/academic-job.aspx 
https://edgeforscholars.org/ 
 
Careers Outside of Academia http://blogs.nature.com/naturejobs/2013/05/21/careers-for-
scientists-away-from-the-bench/ 
 
http://www.sciencemag.org/sites/default/files/documents/away_fr
om_the_bench_1.pdf 
 
Career Planning  
 
http://myidp.sciencecareers.org/ 
 
http://www.apa.org/education/grad/individual-development-
plan.aspx 
 
https://globalhealthtrainingcentre.tghn.org/elearning/ 
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Funding Opportunities https://www.mrc.ac.uk/skills-careers/interactive-career-
framework/#?funderview 
 
https://pivot.cos.com/ 
 
https://www.nsf.gov/funding/ 
 
https://grants.nih.gov/grants/guide/search_guide.htm 
 
Science & Technology 
Fellowships 
https://www.aaas.org/program/science-technology-policy-
fellowships 
 
https://www.aaas.org/page/about-
1?et_rid=330134252&et_cid=1589855 
 
Law, Regulation, and Policy 
 
https://www.fdli.org/ 
 
  
Page 12 of 14 
https://www.hri.global/ 
 
http://www.sciencemag.org/careers/2009/10/finding-your-way-
policy-careers-europe 
 
Medical Writing https://www.amwa.org/ 
 
https://www.emwa.org/ 
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